These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


310 related items for PubMed ID: 11805134

  • 1. Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.
    Zhao X, Tang ZY, Klumpp B, Wolff-Vorbeck G, Barth H, Levy S, von Weizsäcker F, Blum HE, Baumert TF.
    J Clin Invest; 2002 Jan; 109(2):221-32. PubMed ID: 11805134
    [Abstract] [Full Text] [Related]

  • 2. Interaction of hepatitis C virus envelope glycoprotein E2 with the large extracellular loop of tupaia CD81.
    Tian ZF, Shen H, Fu XH, Chen YC, Blum HE, Baumert TF, Zhao XP.
    World J Gastroenterol; 2009 Jan 14; 15(2):240-4. PubMed ID: 19132776
    [Abstract] [Full Text] [Related]

  • 3. [Infection of tupaia hepatocytes with hepatitis C virus in vitro].
    Zhao XP, Tian ZF, Chen YC, Yang C, Tian DY, Yang DL, Hao LJ.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Nov 14; 13(11):805-7. PubMed ID: 16313720
    [Abstract] [Full Text] [Related]

  • 4. Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
    Tong Y, Zhu Y, Xia X, Liu Y, Feng Y, Hua X, Chen Z, Ding H, Gao L, Wang Y, Feitelson MA, Zhao P, Qi ZT.
    J Virol; 2011 Mar 14; 85(6):2793-802. PubMed ID: 21177818
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Variation of hepatitis C virus load, hypervariable region 1 quasispecies and CD81 hepatocyte expression in hepatocellular carcinoma and adjacent non-cancerous liver.
    Young KC, Lin PW, Hsiao WC, Chang TT, Chang YC, Wu HL.
    J Med Virol; 2002 Oct 14; 68(2):188-96. PubMed ID: 12210407
    [Abstract] [Full Text] [Related]

  • 9. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.
    McKeating JA, Zhang LQ, Logvinoff C, Flint M, Zhang J, Yu J, Butera D, Ho DD, Dustin LB, Rice CM, Balfe P.
    J Virol; 2004 Aug 14; 78(16):8496-505. PubMed ID: 15280458
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.
    Meola A, Sbardellati A, Bruni Ercole B, Cerretani M, Pezzanera M, Ceccacci A, Vitelli A, Levy S, Nicosia A, Traboni C, McKeating J, Scarselli E.
    J Virol; 2000 Jul 14; 74(13):5933-8. PubMed ID: 10846074
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.
    Drummer HE, Boo I, Maerz AL, Poumbourios P.
    J Virol; 2006 Aug 14; 80(16):7844-53. PubMed ID: 16873241
    [Abstract] [Full Text] [Related]

  • 14. Primary human hepatocytes in spheroid formation to study hepatitis C infection.
    Chong TW, Smith RL, Hughes MG, Camden J, Rudy CK, Evans HL, Sawyer RG, Pruett TL.
    J Surg Res; 2006 Jan 14; 130(1):52-7. PubMed ID: 16154152
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo.
    Walter E, Keist R, Niederöst B, Pult I, Blum HE.
    Hepatology; 1996 Jul 14; 24(1):1-5. PubMed ID: 8707245
    [Abstract] [Full Text] [Related]

  • 16. CD81 binding regions of hepatitis C virus remain conserved after liver transplantation.
    Lyra AC, Fan X, Di Bisceglie AM.
    Braz J Infect Dis; 2004 Apr 14; 8(2):126-32. PubMed ID: 15361990
    [Abstract] [Full Text] [Related]

  • 17. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.
    Zhang J, Randall G, Higginbottom A, Monk P, Rice CM, McKeating JA.
    J Virol; 2004 Feb 14; 78(3):1448-55. PubMed ID: 14722300
    [Abstract] [Full Text] [Related]

  • 18. Comparison of envelope 2 CD81 binding regions in PBMC-derived versus serum-derived hepatitis C virus isolates: higher conservation of CD81 region 2 in PBMC isolates.
    Welker MW, Welsch C, Ochs D, Hofmann WP, Herrmann E, Piiper A, Hartmann RW, Zeuzem S, Sarrazin C, Kronenberger B.
    J Viral Hepat; 2011 Mar 14; 18(3):181-92. PubMed ID: 20367804
    [Abstract] [Full Text] [Related]

  • 19. Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein: correlation with treatment response in hepatitis C virus-infected patients.
    Hofmann WP, Sarrazin C, Kronenberger B, Schönberger B, Bruch K, Zeuzem S.
    J Infect Dis; 2003 Mar 15; 187(6):982-7. PubMed ID: 12660945
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein.
    Heo TH, Lee SM, Bartosch B, Cosset FL, Kang CY.
    Virus Res; 2006 Oct 15; 121(1):58-64. PubMed ID: 16725222
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.